X0306 4 2020-07-27 0 0001583107 Theravance Biopharma, Inc. TBPH 0001607965 Hindman Andrew A. C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP, Chief Financial Officer Ordinary Shares 2020-07-27 4 A 0 20000 0 A 127458 D On July 1 2019, the reporting person was granted a performance stock unit award that vests based on the achievement of certain performance conditions over a three-year timeframe from 2019 through June 30, 2022 and continued employment. On July 27, 2020, the performance conditions applicable to 20,000 shares were achieved and such shares will vest on August 20, 2021, subject to the reporting person's continued service. Includes 968 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2020. Brett A. Grimaud as Attorney-in-Fact 2020-07-29